Financial Key Figures According to IFRS
|
|
2006
restated |
2007
|
07|06 in %
|
Continuing Operations *
Results:
|
|
|
|
|
| Revenues |
T Euro |
40,575 |
32,885 |
(19) |
| R&D expenses |
T Euro |
30,307 |
36,938 |
22 |
| Operating result ** |
T Euro |
(31,853) |
(46,980) |
(47) |
| Net income (loss) |
T Euro |
(29,000) |
(48,053) |
(66) |
| |
Personnel data: |
|
|
|
|
| Employees as of 31/12 |
|
358 |
386 |
8 |
| |
Per Share: |
|
|
|
|
| Result |
Euro |
(0.44) |
(0.67) |
(53) |
| |
Total Operations
Balance Sheet Data:
|
|
|
|
|
| Total stockholders' equity |
T Euro |
168,320 |
170,553 |
1 |
| Capital expenditure *** |
T Euro |
4,914 |
4,349 |
(11) |
| Cash and investments |
T Euro |
78,723 |
93,676 |
19 |
| Balance sheet total **** |
T Euro |
243,123 |
207,878 |
(14) |
| |
| Cash flow |
T Euro |
22,425 |
(11,374) |
(151) |
- *
- Excluding contributions from Evotec Technologies and from the Chemical Development Business
- **
- Before amortisation and impairment
- ***
- Cash relevant purchase of tangible and intangible assets, excluding finance leases
- ****
- Including assets held for sale